Tofacitinib (CP-690550) Citrate 产品说明书 Chemicals
导航 首页 > 产品 > Featured products
产品编号 DC5165
名称 Tofacitinib (CP-690550) Citrate

化学性质

CAS 540737-29-9
分子式 C22H28N6O8
分子量 504.49
存储条件 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

生物活性

Description
In Vivo
In Vitro

化合物的使用

Kinase Assay
Cell Assay
Animal Administration

参考文献


Tofacitinib (trade name Xeljanz, Formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved For the treatment of rheumatoid arthritis (RA) in the United States and is being studied For treatment of psoriasis
退货政策
如果您对于您的订单不满意，您可以在购买日365天内将产品退回。
下订单的时候请提供您的快递地址以及开票信息
电话: +86-21-58447131
传真: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

网址:
http://www.dcbio.cn/